The Fed. Circ. In April: Hurdles Remain For Generics

By Sean Murray and Jeremiah Helm (May 3, 2024, 12:06 PM EDT) -- This article is part of a monthly column that highlights an important patent appeal from the previous month. In this installment, we examine the Federal Circuit's recent ruling in Salix Pharmaceuticals v. Norwich Pharmaceuticals, and what it means for selling generic drugs with invalidated patents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!